What else was in the news today?

Today’s news contained items that run the spectrum from the clinical value of tomatoes and lycopene via the cardiovascular side effects of LHRH agonists and antagonists to the question of whether proton beam radiation therapy is really cost-effective. So here are the “news shorts” for the day: … READ MORE …

Will active surveillance save us money in management of prostate cancer?

From a health economics point of view, prostate cancer costs a lot of money every year — because a lot of men get diagnosed and treated. … READ MORE …

Your news update: Tuesday, September 16

Today’s news is focused on issues around prevention, screening, and active surveillance:

  • The potential cost-effectiveness of widespread use of finasteride to prevent prostate cancer
  • An update on data from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
  • The argument in favor of active surveillance as first-line management for men with low risk prostate cancer … READ MORE …